1. Spray-Dried mRNA-LNP Powder Enabling Multi-Route Delivery With 3-Year Refrigerated Stability
Sarode A, Patel P, Derosa F, Karve S, Gervier R
The clinical translation of mRNA-lipid nanoparticle (mRNA-LNP) therapeutics is constrained by limited stability of liquid formulations, necessitating ultra-cold storage and restricting global accessibility. Here, we report a spray-dried dry powder platform for mRNA-LNPs that overcomes these limitations while enabling…
Read the article